Clinical trials

  • PEMBROLIZUMAB for Non-small cell lung cancer
  • Isotretinoin for Acne
  • N-[4-({[(1R,4R)-4-HYDROXY-4-METHYLCYCLOHEXYL]METHYL}AMINO)-3-NITROBENZENE-1-SULFONYL]-4-(2-{(2S)-2-[2-(PROPAN-2-YL)PHENYL]PYRROLIDIN1-YL}-7-AZASPIRO[3.5]NONAN-7-YL)-2-[(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)OXY]BENZAMIDE for Multiple myeloma|Relapsed/refractory multiple myeloma
  • FULVESTRANT for Advanced breast cancer | Hormone receptor-positive, HER2-negative advanced breast cancer
  • VOSILASARM for Breast cancer | Hormone receptor positive HER2-negative breast cancer | Metastatic breast cancer
  • SB27 for Non-small cell lung cancer
  • PLACEBO for Seasonal allergic rhinitis | Allergic rhinoconjunctivitis
  • BILAYER ENGINEERED COLLAGEN HYDROGEL-BASED SKIN GRAFT COMPOSED OF AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS for Deep partial-thickness and full-thickness burns
  • IDH305 for Advanced malignancies with IDH1 R132 mutation
  • Dronabinol; Cannabidiol for Neurodegenerative diseases | Amyotrophic lateral sclerosis | Alzheimer's disease | Parkinson's disease
  • OMS906 for Paroxysmal nocturnal hemoglobinuria (PNH)
  • RAY121 for Bullous pemphigoid|Behcet's syndrome|Dermatomyositis|Antiphospholipid syndrome|Immune-mediated necrotizing myopathy|Immune thrombocytopenia